The effect of various forms of treatment of vasculitis on C3, C4 and C5a complement levels in infants and children attending Assiut University Children Hospital (AUCH)

Open Access

Issue		E3S Web Conf. Volume 391, 2023 4^th International Conference on Design and Manufacturing Aspects for Sustainable Energy (ICMED-ICMPC 2023)


Article Number		01135
Number of page(s)		13
DOI		https://doi.org/10.1051/e3sconf/202339101135
Published online		05 June 2023

Åringer M. Inflammatory markers in systemic lupus erythematosus. J Autoimmun. 2020 Jun; 110:102374. DOI: 10.1016/j.jaut.2019.102374. Epub 2019 Dec 4. PMID: 31812331. [CrossRef] [Google Scholar]
Becker R.C. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis. 2020 Oct; 50(3):499-511. DOI: 10.1007/s11239-020-02230-4. PMID: 32700024; PMCID: PMC7373848. [Google Scholar]
Bomback A.S. Anti-complement therapy for glomerular diseases. Adv Chronic Kidney Dis. 2014 Mar; 21(2):152–158. DOI: 10.1053/j.ackd.2013.12.001. PMID: 24602464. [CrossRef] [Google Scholar]
Chimenti M.S., Ballanti E., Triggianese P., Perricone R. Vasculitides and the Complement System: a Comprehensive Review. Clin Rev Allergy Immunol. 2015 Dec; 49(3):333–346. DOI: 10.1007/s12016-014-8453-8. PMID: 25312590. [CrossRef] [PubMed] [Google Scholar]
Ford, J. & Monach, P. (2019). Disease heterogeneity in antineutrophil cytoplasmic antibody-associated vasculitis: implications for therapeutic approaches. The Lancet Rheumatology. 1. e247–e256. 10.1016/S2665-9913(19)30077-3. [CrossRef] [Google Scholar]
Geetha D., Jefferson J.A. ANCA-Associated Vasculitis: Core Curriculum 2020. Am J Kidney Dis. 2020 Jan; 75(1):124–137. DOI: 10.1053/j.ajkd.2019.04.031. Epub 2019 Jul 26. PMID: 31358311. [CrossRef] [Google Scholar]
Gou S.H., Yuan J., Chen M., et al. Circulating complement activation in patients with anti- neutrophil cytoplasmic antibody-associated vasculitis. Kidney International (2012); 83: 129–137. [Google Scholar]
Haiyan Zhang, Chapter 5 - Biomarkers in renal vasculitis, Editor(s): Seema S. Ahuja, Brian Castillo, Kidney Biomarkers, Academic Press, 2020, Pages 209–232, ISBN 9780128159231 [Google Scholar]
Hakroush S., Tampe D., Korsten P., Ströbel P., Zeisberg M., Tampe B. Histopathological Findings Predict Renal Recovery in Severe ANCA-Associated Vasculitis Requiring Intensive Care Treatment. Front Med (Lausanne). 2021 Feb 9; 7:622028. DOI: 10.3389/fmed.2020.622028. PMID: 33634143; PMCID: PMC7900153. [CrossRef] [Google Scholar]
Frank M.M., Hester C.G., Chapter 38 - Immune Complex-Mediated Diseases, Editor(s): N. Franklin Adkinson, Bruce S. Bochner, A. Wesley Burks, William W. Busse, Stephen T. Holgate, Robert F. Lemanske, Robyn E. O’Hehir, Middleton’s Allergy (Eighth Edition), W.B. Saunders, 2014, Pages 602–616, ISBN 9780323085939 [Google Scholar]
(https://www.sciencedirect.com/science/article/pii/B9780323085939000395) [Google Scholar]
Kallenberg C., Heeringa P. Complement is crucial in the pathogenesis of ANCA- associated vasculitis. Kidney International (2018); 83: 16–18. [Google Scholar]
Kliegman, Robert. Nelson Textbook of Pediatrics. Edition 21. Philadelphia, PA: Elsevier, 2020, Chapter 192, Vasculitis Syndromes by Vidya Sivaraman, Edward C. Fels, and Stacy P. Ardoin. [Google Scholar]
Magro C., Mulvey J.J., Berlin D., Nuovo G., Salvatore S., Harp J., Baxter-Stoltzfus A., Laurence J. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020 Jun; 220:1–13. DOI: 10.1016/j.trsl.2020.04.007. Epub 2020 Apr 15. PMID: 32299776; PMCID: PMC7158248. [CrossRef] [Google Scholar]
Ozen S., Pistorio A., Iusan S.M., Bakkaloglu A., Herlin T., Brik R., Buoncompagni A., Lazar C., Bilge I., Uziel Y., Rigante D., Cantarini L., Hilario M.O., Silva C.A., Alegria M., Norambuena X., Belot A., Berkun Y., Estrella A.I., Olivieri A.N., Alpigiani M.G., Rumba I., Sztajnbok F., Tambic-Bukovac L., Breda L., Al-Mayouf S., Mihaylova D., Chasnyk V., Sengler C., Klein-Gitelman M., Djeddi D., Nuno L., Pruunsild C., Brunner J., Kondi A., Pagava K., Pederzoli S., Martini A., Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010 May; 69(5):798–806. DOI: 10.1136/ard.2009.116657. PMID: 20413568. [Google Scholar]
Rennie L. Rhee and Peter A. Merkel, Chapter 92-Classification and Epidemiology of Systemic Vasculitis, Editor(s): Gary S. Firestein, Ralph C. Budd, Sherine E. Gabriel, Iain B. McInnes, James R. O’Dell, 2020, Kelley and Firestein’ s Textbook of Rheumatology (Eleventh Edition), Elsevier Health Sciences, Pages 1584–1549, ISBN 9780323316965, https://doi.org/10.1016/B978-0-323-31696-5.00087-5. [Google Scholar]
(https://www.sciencedirect.com/science/article/pii/B9780323316965000875) [Google Scholar]
Salvador F. ANCA associated vasculitis. Eur J Intern Med. 2020 Apr; 74:18–28. DOI: 10.1016/j.ejim.2020.01.011. Epub 2020 Jan 29. PMID: 32005600. [CrossRef] [Google Scholar]
Schnabel A., Hedrich C.M. Childhood Vasculitis. Front Pediatr. 2019 Jan 10; 6:421. DOI: 10.3389/fped.2018.00421. PMID: 30687686; PMCID: PMC6335362. [CrossRef] [Google Scholar]
Ting T.V. Diagnosis and management of cutaneous vasculitis in children. Pediatr Clin North Am. 2014 Apr; 61(2):321–346. DOI: 10.1016/j.pcl.2013.11.007. Epub 2014 Jan 21. PMID: 24636649. [CrossRef] [Google Scholar]
Vasculitis Syndromes. Vidya Sivaraman, Edward C. Fels and Stacy P. Ardoin. Nelson Textbook of Pediatrics, Chapter 192, 1316–1327. Accessed on Clinical Key. 9/30/2020. [Google Scholar]
Ozen S., Pistorio A., Iusan S.M., Bakkaloglu A., Herlin T., Brik R., Buoncompagni A., Lazar C., Bilge I., Uziel Y., Rigante D., Cantarini L., Hilario M.O., Silva C.A., Alegria M., Norambuena X., Belot A., Berkun Y., Estrella A.I., Olivieri A.N., Alpigiani M.G., Rumba I., Sztajnbok F., Tambic-Bukovac L., Breda L., Al-Mayouf S., Mihaylova D., Chasnyk V., Sengler C., Klein-Gitelman M., Djeddi D., Nuno L., Pruunsild C., Brunner J., Kondi A., Pagava K., Pederzoli S., Martini A., Ruperto N.; Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010 May; 69(5):798–806. DOI: 10.1136/ard.2009.116657. PMID: 20413568. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.